All articles by Vidya Sagar Maddela
Vidya Sagar Maddela
Novavax, Sanofi collaborate on Covid-19 and Influenza vaccines
US-based biotechnology company Novavax and French pharmaceutical company Sanofi have signed a co-exclusive licensing agreement to enhance access to protein-based…
WestGene secures FDA IND approval for mRNA therapeutic cancer vaccine
WestGene, a China-based biotech company focused on mRNA technology, has secured the US Food and Drug Administration (FDA) IND approval…
Novo Nordisk, Metaphore partner to develop advanced obesity medicines
Danish pharmaceutical company Novo Nordisk has entered a research collaboration with Flagship Pioneering and Metaphore Biotechnologies to develop two next-generation…
Siren Biotechnology, Catalent partner to develop AAV gene therapies for cancer
Siren Biotechnology has teamed up with Catalent to support the development and manufacturing of its AAV (adeno-associated viruses) immuno-gene therapies.…
Sentynl acquires Eiger’s Zokinvy to treat rare genetic disease progeria
Sentynl Therapeutics, the US subsidiary of Zydus Lifesciences, has closed its previously announced acquisition of Zokinvy (lonafarnib) from Eiger BioPharmaceuticals.…
Novartis to acquire radioligand therapeutics firm Mariana for $1.75bn
Swiss drugmaker Novartis has agreed to acquire Mariana Oncology, a US-based biotechnology company focused on novel radioligand therapies (RLTs) to…
Astellas, Poseida partner to develop allogeneic cell therapies for cancer
Japanese drugmaker Astellas, through its fully owned subsidiary Xyphos Biosciences, has teamed up with Poseida Therapeutics to develop novel allogeneic…
Bayer, Evotec partner to boost precision medicine for cardiology
German pharmaceutical company Bayer and the life science company Evotec have announced that they are extending their existing collaboration to…
Japan’s ONO Pharmaceutical to acquire Deciphera for $2.4bn
Japanese pharmaceutical company ONO Pharmaceutical has agreed to acquire all outstanding shares of Deciphera Pharmaceuticals for $25.60 per share, for…
Moderna expands collaboration with OpenAI to boost mRNA therapeutics
US-based biotechnology company Moderna and artificial intelligence research firm OpenAI have expanded their ongoing collaboration to unlock the potential of…